Literature DB >> 2667316

Folic acid safety and toxicity: a brief review.

C E Butterworth1, T Tamura.   

Abstract

Oral folic acid (pteroylglutamic acid) is generally regarded as not toxic for normal humans but it may cause neurological injury when given to patients with undiagnosed pernicious anemia. The vitamin should be given with caution to drug-treated epileptic patients because seizure control may be affected. Some studies suggest that folic acid supplements interfere with intestinal zinc absorption in humans and animals but others do not confirm such an effect. The weight of current evidence favors the view that daily supplements of 5-15 mg folic acid do not have significant adverse effects on Zn nutriture in healthy nonpregnant subjects. Because antifolate medications are now being used to treat a wide range of malignant and nonmalignant disorders, further investigation is needed concerning folate metabolism and the safety of supplements in patients with these disorders.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2667316     DOI: 10.1093/ajcn/50.2.353

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  20 in total

1.  Folic acid and the prevention of neural tube defects.

Authors:  N J Wald; C Bower
Journal:  BMJ       Date:  1995-04-22

2.  Factors affecting the use of folic acid supplements in pregnant women in Glasgow.

Authors:  E McGovern; H Moss; G Grewal; A Taylor; S Bjornsson; J Pell
Journal:  Br J Gen Pract       Date:  1997-10       Impact factor: 5.386

Review 3.  Perinatal folate supply: relevance in health outcome parameters.

Authors:  Katalin Fekete; Cristiana Berti; Irene Cetin; Maria Hermoso; Berthold V Koletzko; Tamás Decsi
Journal:  Matern Child Nutr       Date:  2010-10       Impact factor: 3.092

4.  Achieving a public health recommendation for preventing neural tube defects with folic acid.

Authors:  M M Werler; C Louik; A A Mitchell
Journal:  Am J Public Health       Date:  1999-11       Impact factor: 9.308

5.  Alteration of bioelectrically-controlled processes in the embryo: a teratogenic mechanism for anticonvulsants.

Authors:  Sonia Hernández-Díaz; Michael Levin
Journal:  Reprod Toxicol       Date:  2014-05-06       Impact factor: 3.143

Review 6.  Molecular mechanisms underlying the potentially adverse effects of folate.

Authors:  Kyle C Strickland; Natalia I Krupenko; Sergey A Krupenko
Journal:  Clin Chem Lab Med       Date:  2013-03-01       Impact factor: 3.694

7.  A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma.

Authors:  Kana Wu; Elizabeth A Platz; Walter C Willett; Charles S Fuchs; Jacob Selhub; Bernard A Rosner; David J Hunter; Edward Giovannucci
Journal:  Am J Clin Nutr       Date:  2009-10-28       Impact factor: 7.045

8.  Folic acid supplementation inhibits recurrence of colorectal adenomas: a randomized chemoprevention trial.

Authors:  Richard Jaszewski; Sabeena Misra; Martin Tobi; Nadeem Ullah; Jo Ann Naumoff; Omer Kucuk; Edi Levi; Bradley N Axelrod; Bhaumik B Patel; Adhip P N Majumdar
Journal:  World J Gastroenterol       Date:  2008-07-28       Impact factor: 5.742

9.  Folic acid fortification of grain: an economic analysis.

Authors:  P S Romano; N J Waitzman; R M Scheffler; R D Pi
Journal:  Am J Public Health       Date:  1995-05       Impact factor: 9.308

10.  Periodic health examination, 1994 update: 3. Primary and secondary prevention of neural tube defects. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  CMAJ       Date:  1994-07-15       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.